Uwe Schlegel
Klinik Hirslanden(CH)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Brain Metastases and Treatment, Lymphoma Diagnosis and Treatment, Voice and Speech Disorders
Most-Cited Works
- → Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial(2019)568 cited
- → Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma(2010)443 cited
- → Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy(2003)422 cited
- → Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology(2015)418 cited
- → Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients(2000)377 cited
- → Corticosteroids compromise survival in glioblastoma(2016)349 cited